Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease
Bratislava Medical Journal · 2023
DOI: 10.4149/bll_2023_074 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Bratislava Medical Journal, 2023. Verfasst von Yashar Jalali und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Jalali, Y., Gojdicova, A., Sturdik, I., Toth, J., Koller, T., Huorka, M., Jalali, M., Payer, J., & Hlavaty, T. (2023). Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease. Bratislava Medical Journal. https://doi.org/10.4149/bll_2023_074
Vancouver
Jalali Y, Gojdicova A, Sturdik I, Toth J, Koller T, Huorka M, et al. Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease. Bratislava Medical Journal. 2023. doi:10.4149/bll_2023_074
BibTeX
@article{Jalali2023,
author = {Jalali, Yashar and Gojdicova, Anna and Sturdik, Igor and Toth, Jozef and Koller, Tomas and Huorka, Martin and Jalali, Monika and Payer, Juraj and Hlavaty, Tibor},
title = {Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease},
journal = {Bratislava Medical Journal},
year = {2023},
doi = {10.4149/bll_2023_074}
}
EUVIMED